194 related articles for article (PubMed ID: 14561154)
1. CpG oligodeoxynucleotides: a novel therapeutic approach for atopic disorders.
Hussain I; Kline JN
Curr Drug Targets Inflamm Allergy; 2003 Sep; 2(3):199-205. PubMed ID: 14561154
[TBL] [Abstract][Full Text] [Related]
2. Use of CpG oligonucleotides in treatment of asthma and allergic disease.
Fonseca DE; Kline JN
Adv Drug Deliv Rev; 2009 Mar; 61(3):256-62. PubMed ID: 19167442
[TBL] [Abstract][Full Text] [Related]
3. DNA, the immune system, and atopic disease.
Hussain I; Kline JN
J Investig Dermatol Symp Proc; 2004 Jan; 9(1):23-8. PubMed ID: 14870981
[TBL] [Abstract][Full Text] [Related]
4. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma.
Kline JN; Waldschmidt TJ; Businga TR; Lemish JE; Weinstock JV; Thorne PS; Krieg AM
J Immunol; 1998 Mar; 160(6):2555-9. PubMed ID: 9510150
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy of asthma using CpG oligodeoxynucleotides.
Kline JN
Immunol Res; 2007; 39(1-3):279-86. PubMed ID: 17917072
[TBL] [Abstract][Full Text] [Related]
6. CpG oligodeoxynucleotides in asthma.
Hussain I; Kline JN
Curr Opin Investig Drugs; 2001 Jul; 2(7):914-8. PubMed ID: 11757790
[TBL] [Abstract][Full Text] [Related]
7. Improvement of atopic dermatitis in NC/Nga mice by topical application of CpG phosphodiester-ODN.
Kim YS; Kim Y; Lee KJ; Kwon HJ; Kim DS; Kim TY
Int Arch Allergy Immunol; 2007; 144(4):315-24. PubMed ID: 17671391
[TBL] [Abstract][Full Text] [Related]
8. Genetic and environmental factors contributing to the onset of allergic disorders.
Parronchi P; Brugnolo F; Sampognaro S; Maggi E
Int Arch Allergy Immunol; 2000 Jan; 121(1):2-9. PubMed ID: 10686503
[TBL] [Abstract][Full Text] [Related]
9. The immunostimulatory effect of CpG oligodeoxynucleotides on peripheral blood mononuclear cells of healthy dogs and dogs with atopic dermatitis.
Jassies-van der Lee A; Rutten V; Spiering R; van Kooten P; Willemse T; Broere F
Vet J; 2014 Apr; 200(1):103-8. PubMed ID: 24461202
[TBL] [Abstract][Full Text] [Related]
10. Suppressor of cytokine signaling 3 (SOCS3) in Th2 cells evokes Th2 cytokines, IgE, and eosinophilia.
Kubo M; Inoue H
Curr Allergy Asthma Rep; 2006 Feb; 6(1):32-9. PubMed ID: 16476192
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticle-based CpG-oligonucleotide therapy for treating allergic asthma.
Givens BE; Geary SM; Salem AK
Immunotherapy; 2018 Jun; 10(7):595-604. PubMed ID: 29569508
[TBL] [Abstract][Full Text] [Related]
12. SOCS proteins in T helper cell differentiation: implications for allergic disorders?
Inoue H; Kubo M
Expert Rev Mol Med; 2004 Oct; 6(22):1-11. PubMed ID: 15494080
[TBL] [Abstract][Full Text] [Related]
13. Effect of an orally active Th1/Th2 balance modulator, M50367, on IgE production, eosinophilia, and airway hyperresponsiveness in mice.
Kato Y; Manabe T; Tanaka Y; Mochizuki H
J Immunol; 1999 Jun; 162(12):7470-9. PubMed ID: 10358202
[TBL] [Abstract][Full Text] [Related]
14. Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides.
Sur S; Wild JS; Choudhury BK; Sur N; Alam R; Klinman DM
J Immunol; 1999 May; 162(10):6284-93. PubMed ID: 10229876
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 9 activation with CpG oligodeoxynucleotides for asthma therapy.
Kline JN; Krieg AM
Drug News Perspect; 2008 Oct; 21(8):434-9. PubMed ID: 19034349
[TBL] [Abstract][Full Text] [Related]
16. CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice.
Weeratna RD; Brazolot Millan CL; McCluskie MJ; Davis HL
FEMS Immunol Med Microbiol; 2001 Dec; 32(1):65-71. PubMed ID: 11750224
[TBL] [Abstract][Full Text] [Related]
17. Effects of histamine on Th1/Th2 cytokine balance.
Packard KA; Khan MM
Int Immunopharmacol; 2003 Jul; 3(7):909-20. PubMed ID: 12810348
[TBL] [Abstract][Full Text] [Related]
18. Phosphorothioate oligodeoxynucleotides promote the in vitro development of human allergen-specific CD4+ T cells into Th1 effectors.
Parronchi P; Brugnolo F; Annunziato F; Manuelli C; Sampognaro S; Mavilia C; Romagnani S; Maggi E
J Immunol; 1999 Dec; 163(11):5946-53. PubMed ID: 10570281
[TBL] [Abstract][Full Text] [Related]
19. Changes in immune responses to antigen applied to tape-stripped skin with CpG-oligodeoxynucleotide in mice.
Inoue J; Yotsumoto S; Sakamoto T; Tsuchiya S; Aramaki Y
J Control Release; 2005 Nov; 108(2-3):294-305. PubMed ID: 16209897
[TBL] [Abstract][Full Text] [Related]
20. Systemic administration of olygodeoxynucleotides with CpG motifs at priming phase reduces local Th2 response and late allergic rhinitis in BALB/c mice.
Hayashi T; Hasegawa K; Sasaki Y
Inflammation; 2008 Feb; 31(1):47-56. PubMed ID: 17849181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
